SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VERISANTE TECHNOLOGY

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: andre dallaire3/20/2012 11:30:59 AM
   of 254
 
Verisante Technology confirms to us today that the Aura results were published in 'Cancer Research' by the American Association of Cancer Research (AACR)' - folks these guys are top shelf! have a look:

http://en.wikipedia.org/wiki/American_Association_for_Cancer_Research



The American Association for Cancer Research (AACR) is the world's oldest and largest professional association to advancing cancer research. Based in Philadelphia, AACR focuses on all aspects of cancer research including basic, clinical and translational research into the etiology, prevention, diagnosis, and treatment of cancer. Founded in 1907 by 11 physicians and scientists, the organization now has more than 27,000 members in 80 countries.





Cancer Research Journal The American Association for Cancer Research puts out a journal for cancer research it is the most frequently cited cancer journal in the world. Papers are completely reviewed, and only those that meet high standards of scientific merit are accepted for publication. The journal publishes significant, original studies, reviews, and perspectives on all areas of basic, clinical, translational, epidemiological, and prevention research in cancer and the cancer-related biomedical sciences. Some of the topics include biochemistry; chemical, physical, and viral carcinogenesis and mutagenesis; clinical research including clinical trials; endocrinology; epidemiology and prevention; experimental therapeutics, molecular targets, and chemical biology; immunology and immunotherapy including biological therapy; molecular biology, pathobiology, and genetics; radiobiology and radiation oncology; cell and tumor biology; tumor microenvironment; systems biology and other emerging technologies.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext